The effects of methylphenidate and atomoxetine on emotional intelligence, executive function and self-efficacy of 12-18-year-old adolescents with ADHD

Phase 2

Recruiting

• Conditions: Attention Deficit Hyperactivity Disorder (ADHD).; Attention-deficit hyperactivity disorder, predominantly inattentive type; F90.0

• Registration Number: IRCT20160523028008N31
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 76

Inclusion Criteria

Consent to participation in the study by parents
Ages 12 to 18 years
Suffering from Attention Deficit Hyperactivity Disorder (ADHD)

Exclusion Criteria

The existence of a range of psychotic disorders
Autism spectrum disorders
Severe physical illnesses
intellectual disability

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Emotional Intelligence. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Schutt Revised Emotional Intelligence Questionnaire (MSIS).;Executive Function. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Behavior Rating Inventory of Executive Function - Second Edition (BRIEF-2).;Self-Efficacy. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: The Self-Efficacy Questionnaire for Children and Adolescents (SEQ-C).